Conduct of Clinical Trials to Facilitate the Development and Approval of Novel Countermeasures (vaccines, devices, drugs) for Use by the Warfighter

0
125

Funding Opportunity ID: 321453
Opportunity Number: N62645-PA-20-01
Opportunity Title: Conduct of Clinical Trials to Facilitate the Development and Approval of Novel Countermeasures (vaccines, devices, drugs) for Use by the Warfighter
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
CFDA Number(s): 12.340
Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:
Agency Code: DOD-ONR-MED
Agency Name: Department of Defense
NAVAL MEDICAL LOGISTICS COMMAND
Posted Date: Oct 09, 2019
Close Date: Nov 08, 2019
Last Updated Date: Oct 09, 2019
Award Ceiling: $41,822,342
Award Floor: $0
Estimated Total Program Funding:
Expected Number of Awards: 1
Description: The goal of this Cooperative Agreement is to engage in a collaborative research and development (R&D) effort to support the research mission of NAMRU-6. The collaborative R&D effort will include conducting clinical trials, and epidemiologic studies in support of clinical trials, so products can be approved/cleared by the U.S. Food and Drug Administration (FDA) for use by the warfighter.
Version: 1





Visit the Official Webpage For More Details on Conduct of Clinical Trials to Facilitate the Development and Approval of Novel Countermeasures (vaccines, devices, drugs) for Use by the Warfighter